Skip to content

Pulpotomy in Primary Molars Treated With Premixed Bio-ceramic MTA Versus Formocresol

Clinical and Radiographic Evaluation of Pulpotomy in Primary Molars Treated With Premixed Bio-ceramic MTA Versus Formocresol Among a Group of Egyptian Children: A Pilot Study.

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05314842
Enrollment
40
Registered
2022-04-06
Start date
2022-04-01
Completion date
2023-05-01
Last updated
2022-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caries

Brief summary

examine the results of pulpotomy in primary molars using premixed bioceramic MTA versus Formocresol. Clinical and radiographic success rates were used as outcomes.

Detailed description

Primary outcome: Soft-tissue pathology * Post-treatment swelling will be assessed through visual examination by the operator, either intraorally or extra orally. * Sinus tract or fistula will be assessed through visual examination by the operator Secondary outcomes: 1. Pain to the percussion will be assessed by gentle tapping on the tooth with the end of a dental mirror 2. mobility will be assessed through the back of two mirrors 3. radiographic assessments:- for any radiolucency and pathologic root resorption (periapical or bifurcation) will be examined (present or not). clinical assessment on every recall visit during the 3-, 6-, and 12-month follow-up period. • These radiographic assessments will be performed as baseline data at the first visit following the operating procedure, as well as at 3, 6, and 12 months after the baseline.

Interventions

dressing agents in pulpotomized primary molas using formocresol in cariously exposed vital primary molars

DRUGPremixed bioceramic MTA

dressing agents in pulpotomized primary molas using premixed bioceramic MTA in cariously exposed vital primary molars

Sponsors

Sarah Abdelbar Mahmoud
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
4 Years to 6 Years
Healthy volunteers
Yes

Inclusion criteria

* Medically fit and cooperative children. * Pediatric patients aged 4-6 years. * A deep carious lesion in vital primary molars. * Absence of clinical signs and symptoms of pulpal exposure. * Absence of radiographic signs and symptoms of people degeneration. * Positive parental informed consent.

Exclusion criteria

Uncooperative children. * Medically compromised children. * Presence of clinical signs and symptoms of pulpal exposure. * Presence of radiographic signs and symptoms of pulp degeneration. * Physiologic root resorption more than one-third.

Design outcomes

Primary

MeasureTime frameDescription
Soft-tissue pathologyat 0 day* Post-treatment swelling will be assessed through visual examination by the operator, either intraorally or extra orally. * Sinus tract or fistula will be assessed through visual examination by the operator. Binary (present or absent)

Secondary

MeasureTime frameDescription
• Pain to the percussionat 0 daywill be assessed by gentle tapping on the tooth with the end of a dental mirror. Binary (present or absent)
mobilityat 0 day• Mobility is scored on a scale of 1-3 as follows: 1. the movement that is greater than normal (physiological) movement. 2. a maximum of 1 mm in the buccolingual direction. 3. depreciable buccolingual movement of more than 1 mm. Miller's Grades
radiographic indications of radiolucency and pathologic root resorption (periapical or bifurcation) will be examined (present or not).at 0 dayBinary (present or absent)

Contacts

Primary Contactsarah A Mahmoud, B.D.S
sarah_mahmoud@dentistry.cu.edu.eg01023469565
Backup ContactmaiI A Mahmed, PHD
mai.ali@dentistry.cu.edu.eg01012632608

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026